Pomegranate-Linked Compound Shows Promise for Heart Failure Treatment

Researchers at King’s College London have reported promising findings involving urolithin A, a natural compound linked to pomegranates, as a potential avenue for treating heart failure.

The findings point to a possible role for the compound in developing new treatments. They do not, however, establish urolithin A as a proven therapy for patients.

Heart failure occurs when the heart cannot pump blood as effectively as the body needs. Research into potential treatments aims to improve care for people living with the condition.

The brief report did not provide details about the study’s methods or whether the compound was tested in patients. Its potential as a treatment therefore remains uncertain, and the findings should not be interpreted as evidence that eating pomegranates can treat heart failure.